2012
Assessment of Autoantibodies to Meningioma in a Population-based Study
Wiemels JL, Bracci PM, Wrensch M, Schildkraut J, Bondy M, Pfefferle J, Zhou M, Sison J, Calvocoressi L, Claus EB. Assessment of Autoantibodies to Meningioma in a Population-based Study. American Journal Of Epidemiology 2012, 177: 75-83. PMID: 23221727, PMCID: PMC3590036, DOI: 10.1093/aje/kws221.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAntigens, NuclearAutoantibodiesBiomarkers, TumorCell Cycle ProteinsDNA-Binding ProteinsEczemaFemaleHumansHypersensitivityMaleMeningiomaMiddle AgedNuclear Matrix-Associated ProteinsPhosphopyruvate HydrataseReceptors, ImmunologicSex FactorsSmokingSocioeconomic FactorsTumor Suppressor ProteinsUnited StatesConceptsImmune functionAssessment of autoantibodiesUS case-control studyPopulation-based studyTumor-associated antigensCase-control studyEnolase 1Case-control differencesNuclear mitotic apparatus protein 1Risk factorsAutoantibody reactivityImmunoglobulin EIntracranial tumorsMeningioma riskDistinctive etiologyMeningiomasInfection statusSerum samplesProtein 1MenFurther researchMulticenterHigh levelsAutoantibodiesPrevious studies
2011
Genome-Wide High-Density SNP Linkage Search for Glioma Susceptibility Loci: Results from the Gliogene Consortium
Shete S, Lau CC, Houlston RS, Claus EB, Barnholtz-Sloan J, Lai R, Il'yasova D, Schildkraut J, Sadetzki S, Johansen C, Bernstein JL, Olson SH, Jenkins RB, Yang P, Vick NA, Wrensch M, Davis FG, McCarthy BJ, Leung EH, Davis C, Cheng R, Hosking FJ, Armstrong GN, Liu Y, Yu RK, Henriksson R, Consortium T, Melin BS, Bondy ML. Genome-Wide High-Density SNP Linkage Search for Glioma Susceptibility Loci: Results from the Gliogene Consortium. Cancer Research 2011, 71: 7568-7575. PMID: 22037877, PMCID: PMC3242820, DOI: 10.1158/0008-5472.can-11-0013.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedBrain NeoplasmsChildChromosome MappingFamily HealthFemaleGenetic HeterogeneityGenetic Predisposition to DiseaseGenome-Wide Association StudyGenome, HumanGenotypeGliomaHumansLinkage DisequilibriumLod ScoreMaleMiddle AgedPedigreePolymorphism, Single NucleotideUnited StatesYoung AdultFamily and personal medical history and risk of meningioma.
Claus EB, Calvocoressi L, Bondy ML, Schildkraut JM, Wiemels JL, Wrensch M. Family and personal medical history and risk of meningioma. Journal Of Neurosurgery 2011, 115: 1072-7. PMID: 21780859, PMCID: PMC3241000, DOI: 10.3171/2011.6.jns11129.Peer-Reviewed Original ResearchConceptsFirst-degree family historyPersonal medical historyMedical historyFamily historyMeningioma riskEpidemiology of meningiomaPrimary brain tumorsCase-control studyRisk of meningiomaUterine fibroid tumorsImmune conditionsThyroid cancerYoungest caseBreast cancerRole of hormonesBrain tumorsFibroid tumorsImmune systemControl individualsPatientsMeningiomasInfluence of geneticsStrong associationFurther studiesTumors
2009
Prevalence, Complications, and Hospital Charges Associated With Use of Bone-Morphogenetic Proteins in Spinal Fusion Procedures
Cahill KS, H. J, Day A, Claus EB. Prevalence, Complications, and Hospital Charges Associated With Use of Bone-Morphogenetic Proteins in Spinal Fusion Procedures. JAMA 2009, 302: 58-66. PMID: 19567440, DOI: 10.1001/jama.2009.956.Peer-Reviewed Original ResearchConceptsSpinal fusion proceduresAnterior cervical fusionHospital chargesSpinal fusionCervical fusionFusion proceduresUse of BMPAnterior cervical fusion proceduresBone morphogenetic protein useNationwide Inpatient Sample databaseBone morphogenetic proteinGreater hospital chargesPosterior cervical proceduresRetrospective cohort studyWound-related complicationsMore frequent complicationsRate of complicationsTotal hospital chargesCervical fusion proceduresInpatient hospital chargesLength of staySpinal fusion surgeryUS community hospitalsCervical proceduresComplication occurrence